BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31807078)

  • 1. Aberrant Expression Of PDCD4/eIF4A1 Signal Predicts Postoperative Recurrence For Early-Stage Oral Squamous Cell Carcinoma.
    Zhao M; Ding L; Yang Y; Chen S; Zhu N; Fu Y; Ni Y; Wang Z
    Cancer Manag Res; 2019; 11():9553-9562. PubMed ID: 31807078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-infiltrating lymphocyte-derived MLL2 independently predicts disease-free survival for patients with early-stage oral squamous cell carcinoma.
    Zhu N; Ding L; Fu Y; Yang Y; Chen S; Chen W; Zhao M; Zhao X; Lu Z; Ni Y; Hu Q
    J Oral Pathol Med; 2020 Feb; 49(2):126-136. PubMed ID: 31660637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD38 Multi-Functionality in Oral Squamous Cell Carcinoma: Prognostic Implications, Immune Balance, and Immune Checkpoint.
    Ding Z; He Y; Fu Y; Zhu N; Zhao M; Song Y; Huang X; Chen S; Yang Y; Zhang C; Hu Q; Ni Y; Ding L
    Front Oncol; 2021; 11():687430. PubMed ID: 34211854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma.
    Sun Y; Wang S; Zhang X; Wu Z; Li Z; Ding Z; Huang X; Chen S; Jing Y; Zhang X; Ding L; Song Y; Sun G; Ni Y
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher Ki67 expression in fibroblast like cells at invasive front indicates better clinical outcomes in oral squamous cell carcinoma patients.
    Jing Y; Yang Y; Hao F; Song Y; Zhang X; Zhang Y; Huang X; Hu Q; Ni Y
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30341240
    [No Abstract]   [Full Text] [Related]  

  • 6. Distinct expression patterns of Toll-like receptor 7 in tumour cells and fibroblast-like cells in oral squamous cell carcinoma.
    Ni YH; Ding L; Zhang DY; Hou YY; Huang X; Hu Q
    Histopathology; 2015 Nov; 67(5):730-9. PubMed ID: 25828894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma.
    Reis PP; Tomenson M; Cervigne NK; Machado J; Jurisica I; Pintilie M; Sukhai MA; Perez-Ordonez B; Grénman R; Gilbert RW; Gullane PJ; Irish JC; Kamel-Reid S
    Mol Cancer; 2010 Sep; 9():238. PubMed ID: 20831814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor cell-derived TGF-β at tumor center independently predicts recurrence and poor survival in oral squamous cell carcinoma.
    Lu Z; Ding L; Ding H; Hao F; Pu Y; Wang Y; Chen S; Yang Y; Zhao X; Huang X; Zhang L; Wang Z; Hu Q; Ni Y
    J Oral Pathol Med; 2019 Sep; 48(8):696-704. PubMed ID: 31141218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High intratumoral expression of eIF4A1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer.
    Gao C; Guo X; Xue A; Ruan Y; Wang H; Gao X
    Acta Biochim Biophys Sin (Shanghai); 2020 Mar; 52(3):310-319. PubMed ID: 32147684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of EIF4A1 after preoperative brachytherapy predicts better tumor-specific survival in cervical cancer.
    Liang S; Zhou Y; Chen Y; Ke G; Wen H; Wu X
    Int J Gynecol Cancer; 2014 Jun; 24(5):908-15. PubMed ID: 24844222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation Between Programmed Death Receptor-1 Expression in Tumor-Infiltrating Lymphocytes and Programmed Death Ligand-1 Expression in Non-Small Cell Lung Carcinoma.
    Del C Monroig-Bosque P; Driver B; Morales-Rosado JA; Deavers M; Tacha D; Bernicker E; Cagle PT; Miller RA
    Arch Pathol Lab Med; 2018 Nov; 142(11):1388-1393. PubMed ID: 29431467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma.
    Reichert TE; Scheuer C; Day R; Wagner W; Whiteside TL
    Cancer; 2001 Jun; 91(11):2136-47. PubMed ID: 11391595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-L1 expression in tumor-infiltrating lymphocytes (TILs) as an independent predictor of prognosis in patients with pN0 bladder cancer undergoing radical cystectomy.
    Murakami Y; Matsumoto K; Shimizu Y; Ikeda M; Amano N; Shimura S; Ishii D; Sato Y; Iwamura M
    Urol Oncol; 2021 Mar; 39(3):195.e15-195.e23. PubMed ID: 33071109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA CASC2 serves as a ceRNA of microRNA-21 to promote PDCD4 expression in oral squamous cell carcinoma.
    Pan L; Chen H; Bai Y; Wang Q; Chen L
    Onco Targets Ther; 2019; 12():3377-3385. PubMed ID: 31123403
    [No Abstract]   [Full Text] [Related]  

  • 15. High Density of Intratumor CD45RO
    Zhou C; Li J; Wu Y; Diao P; Yang J; Cheng J
    J Oral Maxillofac Surg; 2019 Mar; 77(3):536-545. PubMed ID: 30395824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmed cell death 4 mechanism of action: The model to be updated?
    Vikhreva PN; Kalinichenko SV; Korobko IV
    Cell Cycle; 2017 Oct; 16(19):1761-1764. PubMed ID: 28853972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDCD4 and MIR-21 are promising biomarkers in the follow-up of OED in liquid biopsies.
    Arslan Bozdag L; Açik L; Ersoy HE; Bayir Ö; Korkmaz MH; Mollaoglu N; Gultekin SE
    Oral Dis; 2023 Dec; ():. PubMed ID: 38098243
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Chang C; Wang H; Liu J; Pan C; Zhang D; Li X; Pan Y
    ACS Infect Dis; 2019 Aug; 5(8):1336-1347. PubMed ID: 31243990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoexpression of programmed cell death 4 protein in normal oral mucosa, oral epithelial dysplasia and oral squamous cell carcinoma.
    Desai KM; Kale AD
    J Oral Maxillofac Pathol; 2017; 21(3):462. PubMed ID: 29391736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted intervention of eIF4A1 inhibits EMT and metastasis of pancreatic cancer cells via c-MYC/miR-9 signaling.
    Zhao Y; Wang Y; Chen W; Bai S; Peng W; Zheng M; Yang Y; Cheng B; Luan Z
    Cancer Cell Int; 2021 Dec; 21(1):670. PubMed ID: 34906136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.